TLDR
- Marvell Technology (MRVL) stock fell around 1.9% to $206.48 during midday trading Wednesday
- COO Chris Koopmans sold 10,000 shares at $203.27, totalling approximately $2.03 million under a pre-arranged Rule 10b5-1 plan
- Q2 revenue came in at $2.74 billion, up 37% year-over-year, beating estimates; adjusted EPS of $0.94 topped the $0.93 consensus
- Data center revenue jumped 46% to roughly $2.17 billion, driven by AI infrastructure demand
- Analyst consensus sits at “Moderate Buy” with an average price target of $265.76
Marvell Technology (MRVL) stock was trading down around 1.9% to $206.48 during midday trading on Wednesday, with premarket Thursday showing a further dip of 1.33% to $203.74. The move came after COO Chris Koopmans sold 10,000 stock units at an average price of $203.27, totalling approximately $2.03 million.
Marvell Technology, Inc., MRVL
The sale was executed under a pre-arranged Rule 10b5-1 trading plan. Koopmans retained 217,941 units following the transaction. This is not his first sale this year either. He also sold 10,000 units at $180.50 on August 3rd and another 10,000 at $281.92 on July 1st.
The stock has had a strong run. MRVL is up 231% over the past 12 months, hitting a 12-month high of $329.88. That kind of run tends to make a stock more sensitive to any selling pressure.
Q2 Earnings Beat But Market Remains Cautious
Marvell posted Q2 revenue of $2.74 billion, up 36.5% year-over-year, coming in above the $2.72 billion consensus estimate. Adjusted EPS of $0.94 topped expectations of $0.93.
Data center revenue was a standout, rising 46% to around $2.17 billion. Operating cash flow came in at $605.5 million. The company also raised its Q3 guidance, projecting revenue of $3.15 billion, above the $3.03 billion analyst estimate, and adjusted EPS of $1.10, above the $1.07 consensus.
Despite the beat, investors have some concerns. Free cash flow margins came in softer, and there is uncertainty around the timing of Google-related revenue contributions. Some analysts note the stock trades at a demanding valuation with a P/E ratio of 68.15.
Nasdaq futures were down 0.15% on Thursday while S&P 500 futures edged up 0.03%, reflecting a broader defensive tilt across growth names.
Where Analysts Stand
The analyst picture is broadly positive. Recent price target updates include Oppenheimer raising its target to $325, Craig-Hallum raising to $300, and B. Riley trimming slightly to $315 while keeping a Buy rating. TD Cowen raised its target to $245 with a Hold rating, and Morgan Stanley moved to $246 with an Equal-Weight call.
Goldman Sachs set a $220 target on August 28th, while Royal Bank of Canada maintained an Outperform rating with a $360 target.
The consensus across 39 analysts sits at “Moderate Buy” with an average price target of $265.76.
From a technical standpoint, MRVL is trading 9.1% below its 20-day simple moving average and 8.6% below its 50-day SMA. The 50-day SMA remains above the 200-day SMA following a golden cross in October 2025.
Institutional investors hold 83.51% of the stock. Several institutions added to positions in Q1 and Q2, including Baird Financial Group, which lifted its stake by 22.7% in Q2.
The stock has a 12-month low of $61.44 and a market cap of approximately $181 billion.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.







